Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity.

A Jekle1, R Obst, F Lang

  • 1Department of Physiology, University of Tuebingen, Germany.

Biochemical and Biophysical Research Communications
|June 2, 2000
PubMed
Summary

Expressing CD95 ligand on antigen-presenting cells did not suppress cytotoxic T cell responses. This indicates that CD95 ligand alone is insufficient to control immune responses against autoantigens in autoimmune diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study.

Epidemiology and psychiatric sciences·2022
Same author

Early effects of the antineoplastic agent salinomycin on mitochondrial function.

Cell death & disease·2015
Same author

Mitochondrial ion channels as oncological targets.

Oncogene·2014
Same author

Role of acid sphingomyelinase in the regulation of mast cell function.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

Sphingolipids in psychiatric disorders and pain syndromes.

Handbook of experimental pharmacology·2013
Same author

Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.

Leukemia·2013

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • CD95 ligand (CD95L) expression on various cells may modulate immune responses by inducing apoptosis or inhibiting calcium channels.
  • This mechanism is a potential strategy for downregulating immune responses to autoantigens in autoimmune conditions.

Purpose of the Study:

  • To investigate the efficacy of CD95L expression on antigen-presenting MC57 cells in modifying immune responses to cytotoxic T cells.
  • To assess the potential of this model for controlling autoimmune responses.

Main Methods:

  • MC57 cells engineered to express CD95L were used as antigen-presenting cells.
  • Cytotoxic T cell lines were tested for their sensitivity to CD95L-mediated suppression.
  • Co-incubation assays were performed to evaluate the impact on T cell-mediated cytotoxicity.

Related Experiment Videos

Main Results:

  • Tested cytotoxic T cell lines demonstrated resistance to CD95L expressed by antigen-presenting MC57 cells.
  • Co-incubation of lymphocytes with antigen-presenting cells did not inhibit T lymphocyte-mediated cytotoxicity.

Conclusions:

  • Single expression of CD95 ligand on antigen-presenting cells is insufficient to specifically downregulate CD8+ T cell-mediated immune responses.
  • Further strategies are needed to effectively control immune responses in autoimmune settings using CD95L-based approaches.